Glossary
Bioavailability
Updated February 22, 2026
Bioavailability is the share of an ingredient that reaches blood, tissue, or active site at usable levels compared with the label amount.
Why it matters
Small changes in form, food matrix, and timing can make a large difference in whether a dose behaves like the intended dose.
Relation to mineral, plant, and nutrient forms
- Minerals: citrate, citrate-malate, and chelated forms can change absorption and gastric tolerance.
- Plants/nutrients: extraction methods and matrix complexity shift how much active material is available.
- Fat-soluble compounds: liposomal, emulsified, and lipid-carrying formats often improve practical uptake compared with non-lipid formats.
Form comparison
- Citrate vs citrate-malate: both can be practical, but not interchangeable for every person or outcome.
- Liposomal vs non-liposomal: liposomal formats often improve consistency when timing and diet are variable.
- Chelated forms: often improve tolerability and consistency for some mineral-user profiles.
A practical rule: consider a formula as effectively “different enough” if form, matrix, and fat context differ.
Reading labels and timing as a measurement system
Treat label and timing inputs as three measurement gates:
- form declared on label
- timing and food context
- known blockers/enhancers (calcium, fiber, fat, caffeine)
If one gate changes, keep the other two stable for a test window before attributing response shifts.
Cross-site references
Uncertainty
- Evidence is limited for direct bioavailability comparisons in large mixed-ingredient stacks.
- Evidence is limited on how short-term lifestyle shifts override form-level differences.
How this appears in Unfair
Unfair stores form-level metadata so recommendations compare bioavailability-relevant differences before ranking substitutions.
Clinical safety note
If side effects increase after switching forms, hold escalation and review one variable at a time instead of increasing dose.